|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4489055A
(en)
|
1978-07-19 |
1984-12-18 |
N.V. Sopar S.A. |
Process for preparing biodegradable submicroscopic particles containing a biologically active substance and their use
|
|
US4289872A
(en)
|
1979-04-06 |
1981-09-15 |
Allied Corporation |
Macromolecular highly branched homogeneous compound based on lysine units
|
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
|
US5008050A
(en)
|
1984-06-20 |
1991-04-16 |
The Liposome Company, Inc. |
Extrusion technique for producing unilamellar vesicles
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US5264423A
(en)
|
1987-03-25 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
|
US5276019A
(en)
|
1987-03-25 |
1994-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
|
US5229490A
(en)
|
1987-05-06 |
1993-07-20 |
The Rockefeller University |
Multiple antigen peptide system
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
AU598946B2
(en)
|
1987-06-24 |
1990-07-05 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Nucleoside derivatives
|
|
US4924624A
(en)
|
1987-10-22 |
1990-05-15 |
Temple University-Of The Commonwealth System Of Higher Education |
2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
|
|
US5188897A
(en)
|
1987-10-22 |
1993-02-23 |
Temple University Of The Commonwealth System Of Higher Education |
Encapsulated 2',5'-phosphorothioate oligoadenylates
|
|
WO1989009221A1
(en)
|
1988-03-25 |
1989-10-05 |
University Of Virginia Alumni Patents Foundation |
Oligonucleotide n-alkylphosphoramidates
|
|
US5216141A
(en)
|
1988-06-06 |
1993-06-01 |
Benner Steven A |
Oligonucleotide analogs containing sulfur linkages
|
|
US5457183A
(en)
|
1989-03-06 |
1995-10-10 |
Board Of Regents, The University Of Texas System |
Hydroxylated texaphyrins
|
|
US5256775A
(en)
|
1989-06-05 |
1993-10-26 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides
|
|
US4958013A
(en)
|
1989-06-06 |
1990-09-18 |
Northwestern University |
Cholesteryl modified oligonucleotides
|
|
US5134066A
(en)
|
1989-08-29 |
1992-07-28 |
Monsanto Company |
Improved probes using nucleosides containing 3-dezauracil analogs
|
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
|
US5399676A
(en)
|
1989-10-23 |
1995-03-21 |
Gilead Sciences |
Oligonucleotides with inverted polarity
|
|
ATE269870T1
(de)
|
1989-10-24 |
2004-07-15 |
Isis Pharmaceuticals Inc |
2'-modifizierte oligonukleotide
|
|
US5177198A
(en)
|
1989-11-30 |
1993-01-05 |
University Of N.C. At Chapel Hill |
Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
|
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
|
US5587361A
(en)
|
1991-10-15 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having phosphorothioate linkages of high chiral purity
|
|
US5955589A
(en)
|
1991-12-24 |
1999-09-21 |
Isis Pharmaceuticals Inc. |
Gapped 2' modified oligonucleotides
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
US5608046A
(en)
|
1990-07-27 |
1997-03-04 |
Isis Pharmaceuticals, Inc. |
Conjugated 4'-desmethyl nucleoside analog compounds
|
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
|
US5541307A
(en)
|
1990-07-27 |
1996-07-30 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs and solid phase synthesis thereof
|
|
US5677437A
(en)
|
1990-07-27 |
1997-10-14 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
|
US5618704A
(en)
|
1990-07-27 |
1997-04-08 |
Isis Pharmacueticals, Inc. |
Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
|
|
US5623070A
(en)
|
1990-07-27 |
1997-04-22 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
|
US5610289A
(en)
|
1990-07-27 |
1997-03-11 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogues
|
|
US5489677A
(en)
|
1990-07-27 |
1996-02-06 |
Isis Pharmaceuticals, Inc. |
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
|
|
ES2083593T3
(es)
|
1990-08-03 |
1996-04-16 |
Sterling Winthrop Inc |
Compuestos y metodos para inhibir la expresion de genes.
|
|
US5177196A
(en)
|
1990-08-16 |
1993-01-05 |
Microprobe Corporation |
Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
|
|
FR2677272B1
(fr)
|
1991-06-05 |
1995-03-03 |
Biovecteurs As |
Vecteur particulaire a tropisme selectif, procede de preparation et composition pharmaceutique.
|
|
US5594121A
(en)
|
1991-11-07 |
1997-01-14 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
|
US5484908A
(en)
|
1991-11-26 |
1996-01-16 |
Gilead Sciences, Inc. |
Oligonucleotides containing 5-propynyl pyrimidines
|
|
US5792608A
(en)
|
1991-12-12 |
1998-08-11 |
Gilead Sciences, Inc. |
Nuclease stable and binding competent oligomers and methods for their use
|
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
|
US5700922A
(en)
|
1991-12-24 |
1997-12-23 |
Isis Pharmaceuticals, Inc. |
PNA-DNA-PNA chimeric macromolecules
|
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
|
US5814666A
(en)
|
1992-04-13 |
1998-09-29 |
The United States As Represented By The Department Of Health And Human Services |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
|
US5633360A
(en)
|
1992-04-14 |
1997-05-27 |
Gilead Sciences, Inc. |
Oligonucleotide analogs capable of passive cell membrane permeation
|
|
ATE143730T1
(de)
|
1992-04-22 |
1996-10-15 |
Ecole Polytech |
Lipidmembranen fur biosensoranwendungen
|
|
US5434257A
(en)
|
1992-06-01 |
1995-07-18 |
Gilead Sciences, Inc. |
Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
|
|
US5472881A
(en)
|
1992-11-12 |
1995-12-05 |
University Of Utah Research Foundation |
Thiol labeling of DNA for attachment to gold surfaces
|
|
AU6449394A
(en)
|
1993-03-30 |
1994-10-24 |
Sterling Winthrop Inc. |
Acyclic nucleoside analogs and oligonucleotide sequences containing them
|
|
CA2159629A1
(en)
|
1993-03-31 |
1994-10-13 |
Sanofi |
Oligonucleotides with amide linkages replacing phosphodiester linkages
|
|
US5457187A
(en)
|
1993-12-08 |
1995-10-10 |
Board Of Regents University Of Nebraska |
Oligonucleotides containing 5-fluorouracil
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5596091A
(en)
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
|
US5646269A
(en)
|
1994-04-28 |
1997-07-08 |
Gilead Sciences, Inc. |
Method for oligonucleotide analog synthesis
|
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
ATE509102T1
(de)
|
1994-07-15 |
2011-05-15 |
Univ Iowa Res Found |
Immunomodulatorische oligonukleotide
|
|
ES2336857T3
(es)
|
1995-05-04 |
2010-04-16 |
Gilead Sciences, Inc. |
Complejos de ligandos de acido nucleico.
|
|
US5912340A
(en)
|
1995-10-04 |
1999-06-15 |
Epoch Pharmaceuticals, Inc. |
Selective binding complementary oligonucleotides
|
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
|
US6582921B2
(en)
|
1996-07-29 |
2003-06-24 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses thereof
|
|
US6361944B1
(en)
|
1996-07-29 |
2002-03-26 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
|
US6506564B1
(en)
|
1996-07-29 |
2003-01-14 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
|
US6051698A
(en)
|
1997-06-06 |
2000-04-18 |
Janjic; Nebojsa |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
EP0985033A4
(en)
|
1997-04-04 |
2005-07-13 |
Biosite Inc |
POLYVALENT AND POLYCLONAL LIBRARIES
|
|
US20030104044A1
(en)
|
1997-05-14 |
2003-06-05 |
Semple Sean C. |
Compositions for stimulating cytokine secretion and inducing an immune response
|
|
CA2289702C
(en)
|
1997-05-14 |
2008-02-19 |
Inex Pharmaceuticals Corp. |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
|
US6271209B1
(en)
|
1998-04-03 |
2001-08-07 |
Valentis, Inc. |
Cationic lipid formulation delivering nucleic acid to peritoneal tumors
|
|
US6287765B1
(en)
|
1998-05-20 |
2001-09-11 |
Molecular Machines, Inc. |
Methods for detecting and identifying single molecules
|
|
PT1077722E
(pt)
|
1998-05-22 |
2006-12-29 |
Coley Pharm Group Inc |
Produtos e composições para utilização na indução da imunidade mucosal
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
FR2783170B1
(fr)
|
1998-09-11 |
2004-07-16 |
Pasteur Merieux Serums Vacc |
Emulsion immunostimulante
|
|
US6080580A
(en)
|
1998-10-05 |
2000-06-27 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
|
|
US6228642B1
(en)
|
1998-10-05 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression
|
|
AR022404A1
(es)
|
1999-01-25 |
2002-09-04 |
Photogen Inc |
Metodo y agentes para la terapia de radiacion mejorada
|
|
DE60045739D1
(de)
|
1999-06-25 |
2011-04-28 |
Nanosphere Inc |
Nanopartikel mit gebundenen oligonukleotiden und deren verwendungen
|
|
WO2001003709A1
(en)
|
1999-07-08 |
2001-01-18 |
Cap Biotechnology, Inc. |
Calcium-containing structures and methods of making and using the same
|
|
EP1072679A3
(en)
|
1999-07-20 |
2002-07-31 |
Agilent Technologies, Inc. (a Delaware corporation) |
Method of producing nucleic acid molecules with reduced secondary structure
|
|
DE19935756A1
(de)
|
1999-07-27 |
2001-02-08 |
Mologen Forschungs Entwicklung |
Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
|
|
CA2380947C
(en)
|
1999-08-19 |
2011-11-01 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
|
US20050249794A1
(en)
|
1999-08-27 |
2005-11-10 |
Semple Sean C |
Compositions for stimulating cytokine secretion and inducing an immune response
|
|
SK287400B6
(sk)
|
1999-09-25 |
2010-08-09 |
University Of Iowa Research Foundation |
Prostriedok s obsahom imunostimulačnej nukleovej kyseliny a jeho použitie na stimuláciu imunitnej reakcie
|
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
US6585947B1
(en)
|
1999-10-22 |
2003-07-01 |
The Board Of Trustess Of The University Of Illinois |
Method for producing silicon nanoparticles
|
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
|
KR20020064915A
(ko)
|
1999-11-29 |
2002-08-10 |
에이브이아이 바이오파마 인코포레이티드 |
안티센스 항박테리아 방법 및 조성물
|
|
CA2395742A1
(fr)
|
1999-12-30 |
2001-07-12 |
Aventis Pharma S.A. |
Compositions comprenant des acides nucleiques incorpores dans des particules minerales bilamellaires
|
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
|
US20040131628A1
(en)
|
2000-03-08 |
2004-07-08 |
Bratzler Robert L. |
Nucleic acids for the treatment of disorders associated with microorganisms
|
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
|
CA2404041A1
(en)
|
2000-03-28 |
2001-10-04 |
The Regents Of The University Of California |
Methods for increasing a cytotoxic t lymphocyte response in vivo
|
|
US7291284B2
(en)
|
2000-05-26 |
2007-11-06 |
Northwestern University |
Fabrication of sub-50 nm solid-state nanostructures based on nanolithography
|
|
WO2002004681A2
(en)
|
2000-07-11 |
2002-01-17 |
Northwestern University |
Method of detection by enhancement of silver staining
|
|
US7083958B2
(en)
|
2000-11-20 |
2006-08-01 |
The Board Of Trustees Of The University Of Illinois |
Membrane scaffold proteins
|
|
US7563618B2
(en)
|
2001-03-23 |
2009-07-21 |
Geron Corporation |
Oligonucleotide conjugates
|
|
GB0111279D0
(en)
|
2001-05-10 |
2001-06-27 |
Nycomed Imaging As |
Radiolabelled liposomes
|
|
US7238472B2
(en)
|
2001-05-25 |
2007-07-03 |
Nanosphere, Inc. |
Non-alloying core shell nanoparticles
|
|
CA2449054C
(en)
|
2001-05-30 |
2011-01-04 |
The Scripps Research Institute |
Integrin targeting liposome for nucleic acid delivery
|
|
CA2451974C
(en)
|
2001-06-21 |
2014-10-14 |
Karen L. Fearon |
Chimeric immunomodulatory compounds and methods of using the same
|
|
ES2304467T3
(es)
|
2001-07-10 |
2008-10-16 |
North Carolina State University |
Vehiculo de liberacion de nanoparticulas.
|
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
|
JP4607452B2
(ja)
|
2001-08-07 |
2011-01-05 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節性組成物、製剤およびその使用方法
|
|
EP1414490A1
(en)
|
2001-08-10 |
2004-05-06 |
Dynavax Technologies Corporation |
Immunomodulatory oligonucleotide formulations and methods for use thereof
|
|
AU2002339224B2
(en)
|
2001-09-14 |
2008-10-09 |
Kuros Us Llc |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
|
US7850990B2
(en)
|
2001-10-03 |
2010-12-14 |
Celator Pharmaceuticals, Inc. |
Compositions for delivery of drug combinations
|
|
US20030134810A1
(en)
|
2001-10-09 |
2003-07-17 |
Chris Springate |
Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
|
|
TW200303759A
(en)
|
2001-11-27 |
2003-09-16 |
Schering Corp |
Methods for treating cancer
|
|
ATE373644T1
(de)
|
2002-02-05 |
2007-10-15 |
Bristol Myers Squibb Co |
N-substituierte 3-hydroxy-4-pyridinone und diese enthaltende pharmazeutika
|
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
NZ538628A
(en)
|
2002-08-12 |
2008-06-30 |
Dynavax Tech Corp |
Immunomodulatory compositions, methods of making, and methods of use thereof
|
|
PT2241325E
(pt)
|
2002-10-29 |
2012-04-12 |
Coley Pharm Gmbh |
Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c
|
|
US20040158051A1
(en)
|
2002-11-19 |
2004-08-12 |
Mihri Ozkan |
Mono and dual conjugation of nanostructures and methods of making and using thereof
|
|
GB0227738D0
(en)
|
2002-11-28 |
2003-01-08 |
Univ Liverpool |
Nanoparticle conjugates and method of production thereof
|
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
AU2003300184B8
(en)
|
2002-12-30 |
2009-12-03 |
3M Innovative Properties Company |
Immunostimulatory combinations
|
|
US20060105343A1
(en)
|
2003-01-09 |
2006-05-18 |
Children's Medical Center Corporation |
Methods for diagnosis and prognosis of cancer
|
|
US7354907B2
(en)
|
2003-02-07 |
2008-04-08 |
Idera Pharmaceuticals, Inc. |
Short immunomodulatory oligonucleotides
|
|
AU2004241093B2
(en)
|
2003-05-16 |
2009-08-27 |
Idera Pharmaceuticals, Inc. |
Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
|
|
WO2005008222A2
(en)
|
2003-05-30 |
2005-01-27 |
Nanosphere, Inc. |
Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
GB0313259D0
(en)
|
2003-06-09 |
2003-07-16 |
Consejo Superior Investigacion |
Magnetic nanoparticles
|
|
MXPA05013658A
(es)
|
2003-06-11 |
2006-03-02 |
Hybridon Inc |
Oligonucleotidos inmunomoduladores estabilizados.
|
|
US20050096263A1
(en)
|
2003-10-30 |
2005-05-05 |
Keay Susan K. |
Novel antiproliferative factor and methods of use
|
|
EP1644034B1
(en)
|
2003-07-10 |
2011-01-12 |
Cytos Biotechnology AG |
Composition for enhancing an immune response comprising packaged virus-like particles
|
|
MXPA06000619A
(es)
|
2003-07-15 |
2006-04-11 |
Hybridon Inc |
Estimulacion sinergistica del sistema inmune usando oligonucleotidos inmunoestimuladores y/o compuestos inmunomeros en conjunto con citocinas y/o agentes quimioterapeuticos o terapia de radiacion.
|
|
US20080057128A1
(en)
|
2003-07-18 |
2008-03-06 |
Omeros Corporation |
Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
|
|
CN100393209C
(zh)
|
2003-09-09 |
2008-06-11 |
杰龙公司 |
用于端粒酶抑制的改性寡核苷酸
|
|
CA2536139A1
(en)
|
2003-09-25 |
2005-04-07 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid-lipophilic conjugates
|
|
US7846412B2
(en)
|
2003-12-22 |
2010-12-07 |
Emory University |
Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
|
|
EP1547581A1
(en)
|
2003-12-23 |
2005-06-29 |
Vectron Therapeutics AG |
Liposomal vaccine for the treatment of human hematological malignancies
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
US7959659B2
(en)
|
2004-01-02 |
2011-06-14 |
Advanced Cardiovascular Systems, Inc. |
High-density lipoprotein coated medical devices
|
|
NZ549643A
(en)
|
2004-02-26 |
2009-07-31 |
Layerlab Aktiebolag |
Methods of forming lipid membrane attached linkers comprising contacting membrane with an oligonucleotide having two or more hydrophobic anchoring moieties
|
|
EP1730281A2
(en)
|
2004-04-02 |
2006-12-13 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing il-10 responses
|
|
US20080274454A1
(en)
|
2004-04-07 |
2008-11-06 |
Mirkin Chad A |
Reversible and Chemically Programmable Micelle Assembly With Dna Block-Copolymer Amphiphiles
|
|
GB0409940D0
(en)
|
2004-05-04 |
2004-06-09 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
EP1744620A2
(en)
|
2004-05-12 |
2007-01-24 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
GB0411537D0
(en)
|
2004-05-24 |
2004-06-23 |
Midatech Ltd |
Nanoparticles comprising rna ligands
|
|
WO2005116226A2
(en)
|
2004-05-24 |
2005-12-08 |
Midatech Ltd |
Nanoparticles comprising rna ligands
|
|
WO2006033679A2
(en)
|
2004-05-25 |
2006-03-30 |
Chimeracore, Inc. |
Self-assembling nanoparticle drug delivery system
|
|
EP1604669A1
(en)
|
2004-06-10 |
2005-12-14 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of ATP analogues for treatment of cardiovascular diseases
|
|
US7427405B2
(en)
|
2004-06-15 |
2008-09-23 |
Idera Pharmaceuticals, Inc. |
Immunostimulatory oligonucleotide multimers
|
|
US20060014713A1
(en)
|
2004-06-15 |
2006-01-19 |
Hybridon, Inc. |
Immunostimulatory oligonucleotide multimers
|
|
WO2006012695A1
(en)
|
2004-08-04 |
2006-02-09 |
Panvax Limited |
An immunogenic composition
|
|
WO2006015560A1
(de)
|
2004-08-09 |
2006-02-16 |
Mologen Ag |
Immunmodulierendes mittel in verbindung mit chemotherapeutischen massnahmen
|
|
WO2006044660A2
(en)
|
2004-10-14 |
2006-04-27 |
Vanderbilt University |
Functionalized solid lipid nanoparticles and methods of making and using same
|
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
|
EP1809671B1
(en)
|
2004-11-09 |
2014-07-16 |
University Of Southern California |
CpG/antibody conjugate against cancer
|
|
WO2006056142A1
(en)
|
2004-11-29 |
2006-06-01 |
Changchun Huapu Biotechnology Co., Ltd. |
Cpg single-strand deoxynucleotides for use as adjuvant
|
|
EP1674128A1
(en)
|
2004-12-22 |
2006-06-28 |
Steinbeis-Transferzentrum für Herz-Kreislaufforschung |
Magnetic pole matrices useful for tissue engineering and treatment of disease
|
|
WO2006078777A2
(en)
|
2005-01-19 |
2006-07-27 |
William Marsh Rice University |
Method to fabricate inhomogeneous particles
|
|
KR100704011B1
(ko)
|
2005-02-16 |
2007-04-04 |
한국과학기술원 |
금속나노입자와 양자점의 ｆｒｅｔ에 의한 생체분자특이결합 검출 방법
|
|
AU2006220835B2
(en)
|
2005-03-04 |
2012-01-19 |
Dynavax Technologies Corporation |
Vaccines comprising oligonucleotides having immunostimulatory sequences (ISS) wherein the ISS are conjugated to antigens and stabilized by buffer conditions and further excipients
|
|
US8211712B2
(en)
|
2005-03-29 |
2012-07-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of fabricating lipid bilayer membranes on solid supports
|
|
US8246995B2
(en)
|
2005-05-10 |
2012-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
|
|
ES2731298T3
(es)
|
2005-05-27 |
2019-11-14 |
Univ North Carolina Chapel Hill |
Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
|
|
WO2006138145A1
(en)
|
2005-06-14 |
2006-12-28 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
|
JP2009500412A
(ja)
|
2005-07-07 |
2009-01-08 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
癌の処置のための、抗ｃｔｌａ−４抗体とｃｐｇモチーフ含有合成オリゴデオキシヌクレオチドとの組み合わせ治療
|
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
WO2007047455A2
(en)
|
2005-10-13 |
2007-04-26 |
Northwestern University |
Colorimetric screening of dna binding/intercalating agents with gold nanoparticle probes
|
|
FR2892819B1
(fr)
|
2005-10-28 |
2008-02-01 |
Centre Nat Rech Scient |
Nanoparticules a luminescence persistance pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo
|
|
NZ569086A
(en)
|
2005-12-01 |
2011-07-29 |
Trinity College Dublin |
Compositions comprising a Toll-like receptor (TLR) agonist and an immune modulator for treating Th1-mediated conditions, such as cancer and infectious diseases
|
|
WO2007067733A2
(en)
|
2005-12-09 |
2007-06-14 |
Massachusetts Institute Of Technology |
Compositions and methods to monitor rna delivery to cells
|
|
EP1973608A1
(en)
|
2005-12-14 |
2008-10-01 |
Cytos Biotechnology AG |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
US20070148251A1
(en)
|
2005-12-22 |
2007-06-28 |
Hossainy Syed F A |
Nanoparticle releasing medical devices
|
|
CA2636424A1
(en)
|
2006-01-09 |
2007-10-25 |
The Regents Of The University Of California |
Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agonists for vaccines and tumor immunotherapy
|
|
WO2007089607A2
(en)
|
2006-01-26 |
2007-08-09 |
University Of Massachusetts |
Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same
|
|
US7723045B2
(en)
|
2006-02-10 |
2010-05-25 |
The Regents Of The University Of California |
Assays to predict atherosclerosis and dysfunctional high-density lipoprotein
|
|
US20080045473A1
(en)
|
2006-02-15 |
2008-02-21 |
Coley Pharmaceutical Gmbh |
Compositions and methods for oligonucleotide formulations
|
|
EP1820804A1
(en)
|
2006-02-20 |
2007-08-22 |
Humboldt-Universität zu Berlin |
Lipidated oligonucleotides
|
|
US8361494B2
(en)
|
2006-03-10 |
2013-01-29 |
The Trustees Of The University Of Pennsylvania |
Biomimetic iron-oxide-containing lipoprotein and related materials
|
|
US20100167051A1
(en)
|
2006-03-31 |
2010-07-01 |
Goia Dan V |
Process for Manufacture of Silver-Based Particles and Electrical Contact Materials
|
|
GB0607866D0
(en)
|
2006-04-20 |
2006-05-31 |
Isis Innovation |
Nanostructures
|
|
WO2007131495A2
(de)
|
2006-05-11 |
2007-11-22 |
Mologen Ag |
Multimer zur immunstimulation
|
|
US20110052697A1
(en)
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
WO2008054544A2
(en)
|
2006-05-22 |
2008-05-08 |
Immune Disease Institute, Inc. |
Method for delivery across the blood brain barrier
|
|
US20090280188A1
(en)
|
2006-06-23 |
2009-11-12 |
Northwestern University |
Asymmetric functionalizated nanoparticles and methods of use
|
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
|
AU2007280690C1
(en)
|
2006-07-31 |
2012-08-23 |
Curevac Gmbh |
Nucleic acid of formula (I): GIXmGn, or (II): CIXmCn, in particular as an immune-stimulating agent/adjuvant
|
|
US20080124366A1
(en)
|
2006-08-06 |
2008-05-29 |
Ohlfest John R |
Methods and Compositions for Treating Tumors
|
|
EP2056794A4
(en)
|
2006-08-08 |
2012-12-26 |
Univ Texas |
MULTIPLE ADMINISTRATION OF ACTIVE SUBSTANCES
|
|
WO2008030624A2
(en)
|
2006-09-08 |
2008-03-13 |
The Research Foundation Of State University Of New York |
Nanoparticles for two-photon activated photodynamic therapy and imaging
|
|
PT2468300T
(pt)
|
2006-09-26 |
2018-01-30 |
Infectious Disease Res Inst |
Composição para vacina contendo adjuvante sintético
|
|
US20100099858A1
(en)
|
2006-09-28 |
2010-04-22 |
Mirkin Chad A |
Maximizing Oligonucleotide Loading on Gold Nanoparticle
|
|
ITFI20060263A1
(it)
|
2006-10-27 |
2008-04-28 |
Saeco Ipr Ltd |
Dispositivo emulsionatore per la produzione di latte schiumato e simili e relativo metodo
|
|
US20080181928A1
(en)
|
2006-12-22 |
2008-07-31 |
Miv Therapeutics, Inc. |
Coatings for implantable medical devices for liposome delivery
|
|
US8415461B2
(en)
|
2007-01-19 |
2013-04-09 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic substances and functionalized lipid vesicles including the same
|
|
WO2008089771A1
(en)
|
2007-01-24 |
2008-07-31 |
Syddansk Universitet |
Dna controlled assembly of lipid membranes
|
|
US8507200B2
(en)
|
2007-02-09 |
2013-08-13 |
Northwestern University |
Particles for detecting intracellular targets
|
|
WO2008127789A2
(en)
|
2007-02-27 |
2008-10-23 |
Northwestern University |
Molecule attachment to nanoparticles
|
|
US8658204B2
(en)
|
2007-03-30 |
2014-02-25 |
Otsuka Pharmaceutical Co., Ltd. |
Transpulmonary liposome for controlling drug arrival
|
|
WO2008124632A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
|
US20100234579A1
(en)
|
2007-05-10 |
2010-09-16 |
North Western University |
Silver nanoparticle binding agent conjugates based on moieties with triple cyclic disulfide anchoring groups
|
|
DK2160464T3
(da)
|
2007-05-30 |
2014-08-04 |
Univ Northwestern |
Nukleinsyrefunktionaliserede nanopartikler til terapeutiske anvendelser
|
|
WO2008151022A2
(en)
|
2007-05-31 |
2008-12-11 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
|
US20100183504A1
(en)
|
2007-06-14 |
2010-07-22 |
Fanqing Frank Chen |
Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
|
|
US20080317768A1
(en)
|
2007-06-21 |
2008-12-25 |
Boeing Company |
Bioconjugated nanoparticles
|
|
US20100272813A1
(en)
|
2007-07-23 |
2010-10-28 |
Aarhus Universitet |
Nanoparticle-mediated treatment for inflammatory diseases
|
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
JP5484339B2
(ja)
|
2007-10-05 |
2014-05-07 |
ウェイン ステート ユニバーシティー |
合成物の持続的な放出のためのデンドリマー
|
|
EP2209472A1
(en)
|
2007-10-12 |
2010-07-28 |
The University of North Carolina at Chapel Hill |
Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
|
|
CN101903018B
(zh)
|
2007-10-17 |
2012-09-05 |
韩国科学技术院 |
用于递送核酸基因的ldl样阳离子纳米微粒、其制备方法以及使用其递送核酸基因的方法
|
|
WO2009061515A1
(en)
|
2007-11-09 |
2009-05-14 |
Northeastern University |
Self-assembling micelle-like nanoparticles for systemic gene delivery
|
|
US9265729B2
(en)
|
2007-12-06 |
2016-02-23 |
The University Of Tokushima |
Nanofunctional silica particles and manufacturing method thereof
|
|
US20090148384A1
(en)
|
2007-12-10 |
2009-06-11 |
Fischer Katrin |
Functionalized, solid polymer nanoparticles comprising epothilones
|
|
CN105903029A
(zh)
|
2007-12-12 |
2016-08-31 |
大学健康网络 |
高密度脂蛋白样肽磷脂支架（“hpps”）纳米颗粒
|
|
WO2009089115A1
(en)
|
2008-01-04 |
2009-07-16 |
Hormel Foods Corporation |
Encapsulation of oxidatively unstable compounds
|
|
JP2011518116A
(ja)
|
2008-02-21 |
2011-06-23 |
ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション |
トール様受容体３拮抗薬としての超小型ｒｎａ
|
|
RU2496482C2
(ru)
|
2008-03-05 |
2013-10-27 |
Бакстер Интернэшнл Инк. |
Композиции и способы для доставки лекарственных средств
|
|
EP2257306B1
(en)
|
2008-03-25 |
2014-05-07 |
Juvaris Biotherapeutics, Inc. |
Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
|
|
EP2105145A1
(en)
|
2008-03-27 |
2009-09-30 |
ETH Zürich |
Method for muscle-specific delivery lipid-conjugated oligonucleotides
|
|
JP2011518222A
(ja)
|
2008-04-21 |
2011-06-23 |
スリーエム イノベイティブ プロパティズ カンパニー |
酸化窒素放出組成物、デバイス、及び方法
|
|
CA2722183C
(en)
|
2008-04-25 |
2018-09-18 |
Northwestern University |
Nanostructures suitable for sequestering cholesterol and other molecules
|
|
JP5721620B2
(ja)
|
2008-05-02 |
2015-05-20 |
キャンサー・リサーチ・テクノロジー・リミテッドＣａｎｃｅｒ Ｒｅｓｅａｒｃｈ Ｔｅｃｈｎｏｌｏｇｙ Ｌｉｍｉｔｅｄ |
免疫応答を刺激するための作製物および方法
|
|
WO2009158678A1
(en)
|
2008-06-27 |
2009-12-30 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use therefor
|
|
CA2733057A1
(en)
|
2008-08-04 |
2010-02-11 |
Idera Pharmaceuticals, Inc. |
Modulation of toll-like receptor 3 expression by antisense oligonucleotides
|
|
US20100047188A1
(en)
|
2008-08-04 |
2010-02-25 |
Idera Pharmaceuticals, Inc. |
Modulation of toll-like receptor 8 expression by antisense oligonucleotides
|
|
CA2734950A1
(en)
|
2008-08-28 |
2010-03-04 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
WO2010043039A1
(en)
|
2008-10-16 |
2010-04-22 |
University Of Saskatchewan |
Combination adjuvant formulation
|
|
US8574582B2
(en)
|
2008-10-31 |
2013-11-05 |
Janssen Biotech, Inc. |
Methods for mediating fibrotic response
|
|
EP2370112B1
(en)
|
2008-11-24 |
2017-04-05 |
Bonus Cellora Ltd. |
Implantable liposome embedded matrix composition, and uses thereof
|
|
CN106955360A
(zh)
|
2008-11-24 |
2017-07-18 |
西北大学 |
多价rna纳米颗粒组合物
|
|
HUE027823T2
(hu)
|
2008-12-09 |
2016-11-28 |
Coley Pharm Group Inc |
Immunstimuláló oligonukleotidok
|
|
WO2010078516A2
(en)
|
2009-01-01 |
2010-07-08 |
Cornell University |
Multifunctional nucleic acid nano-structures
|
|
WO2010081049A1
(en)
|
2009-01-08 |
2010-07-15 |
Northwestern University |
Inhibition of bacterial protein production by polyvalent oligonucleotide modified nanoparticle conjugates
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
US20110293565A1
(en)
|
2009-01-30 |
2011-12-01 |
Idera Pharmaceuticals, Inc. |
Novel synthetic agonists of tlr9
|
|
WO2010091293A1
(en)
|
2009-02-06 |
2010-08-12 |
The Regents Of The University Of California |
Plasmonic system for detecting binding of biological molecules
|
|
AR070368A2
(es)
|
2009-02-12 |
2010-03-31 |
Smithkline Beecham Biolog |
Procedimiento para la preparacion de una composicion de vacuna que comprende un inmunoestimulante un antigeno y una sal metalica y uso de dicha composicion para preparar un medicamento.composicion de vacuna
|
|
AU2010223967B2
(en)
|
2009-03-12 |
2015-07-30 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
|
|
EP2406379A4
(en)
|
2009-03-13 |
2012-09-26 |
Egen Inc |
COMPOSITIONS AND METHODS FOR RELEASING BIOLOGICALLY ACTIVE RNA
|
|
EP2419535B1
(en)
|
2009-04-15 |
2022-08-17 |
Northwestern University |
Delivery of oligonucleotide-functionalized nanoparticles
|
|
NZ597308A
(en)
|
2009-05-29 |
2013-07-26 |
Envision Scient Private Ltd |
Re-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano- encapsulated drug in human artery with body ph
|
|
PT3305302T
(pt)
|
2009-06-17 |
2018-12-14 |
Biogen Ma Inc |
Composições e métodos de modulação de excisões de smn2 em um sujeito
|
|
WO2010147387A2
(en)
|
2009-06-18 |
2010-12-23 |
Industry Academic Cooperation Foundation, Hallym University |
Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides as active ingredients
|
|
KR101346197B1
(ko)
|
2009-07-17 |
2014-02-06 |
한림대학교 산학협력단 |
리포좀에 포집된 올리고뉴클레오타이드 및 에피토프를 포함하는 면역증강용 조성물
|
|
WO2011017382A2
(en)
|
2009-08-03 |
2011-02-10 |
The Regents Of The University Of California |
Nanofibers and morphology shifting micelles
|
|
WO2011017456A2
(en)
|
2009-08-04 |
2011-02-10 |
Northwestern University |
Localized delivery of nanoparticles for therapeutic and diagnostic applications
|
|
WO2011017690A2
(en)
|
2009-08-07 |
2011-02-10 |
Northwestern University |
Intracellular delivery of contrast agents with functionalized nanoparticles
|
|
CA2772660A1
(en)
|
2009-09-01 |
2011-03-10 |
Northwestern University |
Delivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers
|
|
WO2011028847A1
(en)
|
2009-09-01 |
2011-03-10 |
Northwestern University |
Polyvalent polynucleotide nanoparticle conjugates as delivery vehicles for a chemotherapeutic agent
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
US20120288935A1
(en)
|
2009-09-23 |
2012-11-15 |
Northwestern University |
"Click" Nanoparticle Conjugates
|
|
US20110111974A1
(en)
|
2009-10-23 |
2011-05-12 |
Northwestern University |
Short Duplex Probes for Enhanced Target Hybridization
|
|
DK2494075T3
(en)
|
2009-10-30 |
2018-07-23 |
Univ Northwestern |
TABLE-MANAGED NANOCONJUGATES
|
|
US9138418B2
(en)
|
2009-12-09 |
2015-09-22 |
William Marsh Rice University |
Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles
|
|
AU2010334799A1
(en)
|
2009-12-23 |
2012-07-12 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Influenza targets
|
|
WO2011079290A1
(en)
|
2009-12-24 |
2011-06-30 |
Northwestern University |
Oligonucleotide specific uptake of nanoconjugates
|
|
WO2011091065A2
(en)
|
2010-01-19 |
2011-07-28 |
Northwestern University |
Synthetic nanostructures including nucleic acids and/or other entities
|
|
EP2399608B1
(en)
|
2010-03-05 |
2020-07-08 |
Sebastian Fuchs |
Immunomodulating nanoparticulate composition for use in inhalation therapy
|
|
US20130101512A1
(en)
|
2010-03-12 |
2013-04-25 |
Chad A. Mirkin |
Crosslinked polynucleotide structure
|
|
WO2011127405A1
(en)
|
2010-04-08 |
2011-10-13 |
Sanford-Burnham Medical Research Institute |
Methods and compositions for enhanced delivery of compounds
|
|
EP3165540A1
(en)
|
2010-04-13 |
2017-05-10 |
Celldex Therapeutics, Inc. |
Antibodies that bind human cd27 and uses thereof
|
|
BR112012027745A2
(pt)
|
2010-04-27 |
2017-01-10 |
Univ Johns Hopkins |
método e composição imunogênica para tratamento de neoplásia
|
|
KR101198715B1
(ko)
|
2010-05-14 |
2012-11-13 |
한국생명공학연구원 |
핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
|
|
AU2011258165B2
(en)
|
2010-05-26 |
2016-11-17 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
|
NZ603527A
(en)
|
2010-05-28 |
2014-10-31 |
Zoetis Belgium S A |
Vaccines comprising cholesterol and cpg as sole adjuvant - carrier molecules
|
|
WO2011156895A2
(en)
|
2010-06-14 |
2011-12-22 |
National Research Council Of Canada |
Magnetic nanoparticles and uses thereof
|
|
WO2012006634A2
(en)
|
2010-07-09 |
2012-01-12 |
The Board Of Trustees Of The University Of Illiniois |
Prostate specific antigen (psa) peptide therapy
|
|
CA2801523C
(en)
|
2010-07-30 |
2021-08-03 |
Curevac Gmbh |
Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
|
|
US9549901B2
(en)
|
2010-09-03 |
2017-01-24 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
|
US20130095039A1
(en)
|
2010-09-30 |
2013-04-18 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid-mediated shape control of nanoparticles
|
|
AR083561A1
(es)
|
2010-10-26 |
2013-03-06 |
Ac Immune Sa |
Preparacion de una construccion antigenica
|
|
WO2012084991A1
(en)
|
2010-12-21 |
2012-06-28 |
Index Pharmaceuticals Ab |
Biologically active oligonucleotides capable of modulating the immune system ii
|
|
CA2824526C
(en)
|
2011-01-11 |
2020-07-07 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
WO2012177624A2
(en)
|
2011-06-21 |
2012-12-27 |
The Johns Hopkins University |
Focused radiation for augmenting immune-based therapies against neoplasms
|
|
WO2013009701A2
(en)
|
2011-07-08 |
2013-01-17 |
The University Of North Carolina At Chapel Hill |
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
|
|
WO2013012628A2
(en)
*
|
2011-07-15 |
2013-01-24 |
The University Of Georgia Research Foundation, Inc. |
Immune-stimulating photoactive hybrid nanoparticles
|
|
EP2548571A1
(en)
|
2011-07-22 |
2013-01-23 |
Institut Curie |
Compositions having means for targeting at least one antigen to dendritic cells
|
|
JP2014521687A
(ja)
|
2011-07-29 |
2014-08-28 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
|
|
WO2013033513A1
(en)
|
2011-08-31 |
2013-03-07 |
University Of Georgia Research Foundation, Inc. |
Apoptosis-targeting nanoparticles
|
|
CA2848359A1
(en)
|
2011-09-11 |
2013-03-14 |
Aurasense, Llc |
Cellular uptake control systems
|
|
US9308253B2
(en)
|
2011-09-19 |
2016-04-12 |
The Johns Hopkins University |
Cancer immunotherapy
|
|
WO2013043569A1
(en)
|
2011-09-20 |
2013-03-28 |
Vical Incorporated |
Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
|
|
JP6240077B2
(ja)
|
2011-10-06 |
2017-11-29 |
イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． |
Ｔｌｒ２を活性化するか、またはその活性を増加させるアジュバントを含むリポソーム組成物およびその使用
|
|
JP2015509085A
(ja)
|
2012-01-01 |
2015-03-26 |
キュービーアイ エンタープライゼズ リミテッドＱｂｉ Ｅｎｔｅｒｐｒｉｓｅｓ Ｌｔｄ． |
治療剤および診断剤の選択的送達のためのｅｎｄｏ１８０を標的とする粒子
|
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
|
WO2013123424A1
(en)
|
2012-02-17 |
2013-08-22 |
Mayo Foundation For Medical Education And Research |
Methods and materials for generating cd8+ t cells having the ability to recognize cancer cells expressing a her2/neu polypeptide
|
|
JP2015513543A
(ja)
|
2012-02-22 |
2015-05-14 |
ノースウェスタン ユニバーシティ |
癌および他の状態を処置するためのナノ構造体
|
|
JP6375289B2
(ja)
|
2012-04-05 |
2018-08-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
免疫刺激組成物およびその使用方法
|
|
AU2013255511B2
(en)
|
2012-05-04 |
2016-01-28 |
Pfizer Inc. |
Prostate-associated antigens and vaccine-based immunotherapy regimens
|
|
US9750819B2
(en)
|
2012-05-23 |
2017-09-05 |
Ohio State Innovation Foundation |
Lipid nanoparticle compositions and methods of making and methods of using the same
|
|
CN104684923B
(zh)
|
2012-07-13 |
2018-09-28 |
株式会社新日本科学 |
手性核酸佐剂
|
|
CN112587671A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
|
WO2014025795A1
(en)
|
2012-08-07 |
2014-02-13 |
Northeastern University |
Compositions for the delivery of rna and drugs into cells
|
|
US9095625B2
(en)
|
2012-08-31 |
2015-08-04 |
University Of Massachusetts |
Graft-copolymer stabilized metal nanoparticles
|
|
JP2016507057A
(ja)
|
2013-01-31 |
2016-03-07 |
プライベール インコーポレイティド |
検査デバイス
|
|
EP3845248A1
(en)
|
2013-02-05 |
2021-07-07 |
1Globe Health Institute LLC |
Biodegradable and clinically-compatible nanoparticles as drug delivery carriers
|
|
US9968673B2
(en)
|
2013-02-26 |
2018-05-15 |
Commissariat á l'ènergie atomique et aux ènergies alternatives |
Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
|
|
ES2986545T3
(es)
|
2013-03-01 |
2024-11-11 |
California Inst Of Techn |
Nanopartículas dirigidas
|
|
MX384232B
(es)
|
2013-03-14 |
2025-03-14 |
Jerome J Schentag |
Vesiculas colestosomicas para incorporacion de moleculas en quilomicrones.
|
|
CN103212089B
(zh)
*
|
2013-04-07 |
2016-08-24 |
中国科学院上海应用物理研究所 |
一种碳纳米材料-免疫刺激序列复合物的制备方法及其应用
|
|
US9617544B2
(en)
|
2013-04-11 |
2017-04-11 |
The Board Of Trustees Of The University Of Illinois |
Nanoparticle mediated delivery of siRNA
|
|
AR095882A1
(es)
|
2013-04-22 |
2015-11-18 |
Hoffmann La Roche |
Terapia de combinación de anticuerpos contra csf-1r humano con un agonista de tlr9
|
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
|
CN105579582A
(zh)
|
2013-07-25 |
2016-05-11 |
埃克西奎雷股份有限公司 |
用于预防和治疗用途的作为免疫刺激剂的基于球形核酸的构建体
|
|
JP2016534094A
(ja)
|
2013-07-25 |
2016-11-04 |
イグジキュア, インコーポレーテッドExicure, Inc. |
免疫調節剤としての球状核酸に基づくコンストラクト
|
|
JP6527516B2
(ja)
|
2013-12-03 |
2019-06-05 |
ノースウェスタン ユニバーシティ |
リポソーム粒子、前述のものを作製する方法及びその使用
|
|
WO2015108047A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
|
GB2523187A
(en)
|
2014-02-18 |
2015-08-19 |
Mologen Ag |
Covalently closed non-coding immunomodulatory DNA construct
|
|
US20170175121A1
(en)
|
2014-04-03 |
2017-06-22 |
Exicure, Inc. |
Self assembling nucleic acid nanostructures
|
|
AU2015269412B2
(en)
|
2014-06-04 |
2020-03-12 |
Exicure Operating Company |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
TW201620526A
(zh)
|
2014-06-17 |
2016-06-16 |
愛羅海德研究公司 |
用於抑制α－１抗胰蛋白酶基因表現之組合物及方法
|
|
WO2016004168A1
(en)
|
2014-07-01 |
2016-01-07 |
Aurasense Therapeutics, Llc |
Spherical nanoparticles as antibacterial agents
|
|
CA2963931A1
(en)
|
2014-10-06 |
2016-04-14 |
Exicure, Inc. |
Anti-tnf compounds
|
|
JP6991857B2
(ja)
|
2014-10-10 |
2022-01-13 |
イデラ ファーマシューティカルズ インコーポレイテッド |
Ｔｌｒ９アゴニストをチェックポイント阻害剤と共に用いるがんの治療
|
|
WO2016115320A1
(en)
|
2015-01-14 |
2016-07-21 |
Exicure, Inc. |
Nucleic acid nanostructructures with core motifs
|
|
WO2016134104A1
(en)
|
2015-02-18 |
2016-08-25 |
Exicure, Inc. |
Immuno-regulatory lipid containing spherical nucleic acids
|
|
WO2016149323A1
(en)
|
2015-03-16 |
2016-09-22 |
Exicure, Inc. |
Immunomodulatory spherical nucleic acids
|
|
US10078092B2
(en)
|
2015-03-18 |
2018-09-18 |
Northwestern University |
Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules
|
|
US20180214376A1
(en)
|
2015-07-14 |
2018-08-02 |
Exicure, Inc. |
Spherical nucleic acid (sna)-mediated delivery of lipid-complexes to cells
|
|
WO2017011618A1
(en)
|
2015-07-15 |
2017-01-19 |
The Curators Of The University Of Missouri |
Targeted nanoparticle conjugate and method for co-delivery of sirna and drug
|
|
JP2018525037A
(ja)
|
2015-08-24 |
2018-09-06 |
ハロー−バイオ・アールエヌエーアイ・セラピューティックス、インコーポレイテッド |
遺伝子発現の調節のためのポリヌクレオチドナノ粒子及びその使用
|
|
LU92821B1
(en)
|
2015-09-09 |
2017-03-20 |
Mologen Ag |
Combination comprising immunostimulatory oligonucleotides
|
|
US20190142739A1
(en)
|
2016-04-19 |
2019-05-16 |
Exicure, Inc. |
Topical administration of therapeutic agents and oligonucleotide formulations
|
|
EP3452598A4
(en)
|
2016-05-06 |
2020-04-29 |
Exicure, Inc. |
LIPOSOMAL SPHERICAL NUCLEIC ACID (ANS) CONSTRUCTS HAVING ANTISENSE OLIGONUCLEOTIDES (ASO) FOR THE SPECIFIC INACTIVATION OF INTERLEUKIN 17 RECEPTOR RNA
|
|
EP3452599A4
(en)
|
2016-05-06 |
2020-04-01 |
Exicure, Inc. |
Spherical nucleic acid tlr9 agonists
|
|
FI3922279T3
(fi)
|
2016-08-30 |
2025-02-04 |
Dana Farber Cancer Inst Inc |
Lääkkeenantokoostumuksia ja niiden käyttötapoja
|
|
JP7200093B2
(ja)
|
2016-09-15 |
2023-01-06 |
アイデラ・ファーマシューティカルズ，インコーポレーテッド |
がん治療用ｔｌｒ９アゴニストを用いた免疫調節
|
|
US20190374650A1
(en)
|
2017-02-22 |
2019-12-12 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of polymer/biomacromolecule conjugates
|
|
US11696954B2
(en)
|
2017-04-28 |
2023-07-11 |
Exicure Operating Company |
Synthesis of spherical nucleic acids using lipophilic moieties
|
|
WO2019168558A1
(en)
|
2018-02-28 |
2019-09-06 |
Exicure, Inc. |
Liposomal spherical nucleic acid (sna) constructs for survival of motor neuron (sma) inhibitors
|
|
US20210002640A1
(en)
|
2018-02-28 |
2021-01-07 |
Exicure, Inc. |
Liposomal spherical nucleic acid (sna) constructs for survival of motor neuron (sma) inhibitors
|